Kingsway Financial Services Inc. — Q2 2013 Form 10-Q
Reporting period: Quarter and six months ended June 30, 2013. Amounts are in U.S. dollars; financial statement amounts are in millions unless otherwise noted. Kingsway is a holding company operating primarily in property and casualty insurance, through Insurance Underwriting and Insurance Services.
Financial results
| Metric | Q2 2013 | Q2 2012 | Six months 2013 | Six months 2012 |
|---|---|---|---|---|
| Total revenue | $43.9 | $39.7 | $77.5 | $76.4 |
| Net loss | $9.7 | $7.7 | $27.0 | $20.2 |
| Net loss attributable to common shareholders | $10.3 | $6.0 | $27.7 | $17.0 |
| Loss per share, basic and diluted | $0.74 | $0.59 | $2.05 | $1.54 |
| Net cash used in operating activities | — | $25.6 | $30.9 |
Quarterly revenue growth reflected higher Insurance Services fees and commissions, partly offset by lower earned premiums and investment results. Total revenue also included fair-value changes in debt: a $2.3 million gain in Q2, versus a $2.4 million loss a year earlier. The six-month period included a $6.6 million debt fair-value loss. Revenue is therefore not solely a measure of operating performance.
At June 30, total assets were $353.1 million, versus $372.8 million at year-end 2012; cash and equivalents were $71.4 million, versus $80.8 million. Total investments were $109.3 million. Total liabilities were $312.2 million and total equity was $40.9 million, down from $65.4 million. Common shareholders’ equity was $39.5 million, below the NYSE’s $50 million threshold cited in the filing.
Debt instruments carried at fair value totaled $67.2 million on the balance sheet; their aggregate principal was $131.9 million. This included $26.4 million principal of senior notes due February 1, 2014, $90.5 million principal of subordinated debt, and LROC preferred units. The company had deferred trust-preferred interest payments since 2011; $10.5 million of deferred interest was accrued at quarter-end. Interest expense was $1.9 million in Q2 and $3.8 million year to date.
Operations and changes versus prior periods
- Insurance Underwriting: Q2 net premiums earned fell 8.7% to $28.3 million; six-month earned premiums declined 6.5% to $56.4 million. Segment operating losses widened to $5.4 million for Q2 and $9.7 million for the first half. The combined ratio increased to 126.7% for Q2 and 125.5% year to date, indicating underwriting losses. Management cited catastrophe losses, lower earned premiums at businesses in run-off, and restructuring costs. Six-month gross written premiums rose 5.7%, while net written premiums fell 12.2%, reflecting reinsurance and run-off effects.
- Insurance Services: Fees and commissions rose 49.4% to $12.1 million in Q2 and increased to $25.2 million for the first half, primarily reflecting IWS, acquired in late 2012. Segment results shifted to a $0.1 million Q2 loss from $1.0 million income; first-half income declined to $1.3 million from $2.7 million. The filing cites acquired-intangible amortization and lower ARS volumes.
- Investment income was $0.8 million in Q2, broadly unchanged, and $1.4 million year to date versus $1.6 million. The first-half realized loss of $1.4 million primarily reflected the sale of Atlas common shares.
- Q2 and first-half results included a $1.8 million impairment of Atlas preferred stock, based on its subsequent sale terms, and a $1.4 million write-down of a Miami property held for sale. Restructuring expense was $0.9 million for the first half.
Liquidity, outlook, risks and contingencies
Operating cash outflow of $25.6 million was partly offset by $16.7 million of investing inflows, including $13.6 million from the Atlas common-stock sale. Cash declined $9.5 million during the first half. Management said cash and liquid investments at insurance subsidiaries were expected to support policyholder and operating obligations, but emphasized that the holding company did not have funds to repay the $26.4 million senior-note principal due February 2014 and meet all other obligations without further action.
After quarter-end, the company completed the sale of its Atlas preferred shares for $16.2 million. Atlas paid $7.5 million cash plus approximately $0.8 million from warrant proceeds at closing; any unpaid purchase price was to be evidenced by promissory notes, with repayment due no later than April 30, 2014. Kingsway also announced a rights offering intended to raise approximately $12.5 million net, expiring September 6, 2013; completion was not assured. Management stated it might need to raise capital, sell assets, or restructure debt, and gave no assurance it could meet the February 2014 maturity.
- The company received NYSE notice of non-compliance because market capitalization and shareholders’ equity were below applicable listing criteria. It submitted a compliance plan and said shares would continue trading during the stated 18-month remediation period, subject to other listing standards. Regaining compliance was not assured.
- Debt covenants restrict additional borrowing and certain payments. At June 30, the reported total debt-to-total capital ratio was 65.8% and senior debt-to-total capital was 34.6%.
- At December 31, 2012, Amigo’s risk-based capital ratio was 157%, at the regulatory company-action level. Its comprehensive run-off plan remained subject to Florida regulatory approval. Most other insurance subsidiaries exceeded the cited 200% threshold at that date.
- Legal proceedings arise in the ordinary course; the company said potential losses could not be estimated and individual matters could materially affect results or financial condition. A third party had received a $12.0 million customs-bond demand involving Lincoln General; no demand had been made on Kingsway, which recorded no liability and said it believed it had substantial defenses.
- The company had $4.0 million of unfunded commitments to limited-liability investments. It also identified uncertainty in loss-reserve estimates, investment valuations, deferred taxes and debt fair values. A full valuation allowance was maintained on net deferred tax assets.
Guidance: The filing provides no specific earnings or revenue forecast. Management’s forward-looking statements are subject to risks, including the ability to complete the rights offering, meet debt obligations, and execute run-off and restructuring plans.
Key facts for investors to verify
- Whether the Atlas preferred-stock sale proceeds still due under the transaction were collected on schedule, and the terms and collectability of any promissory notes.
- Whether the rights offering closed, how much net capital it raised, and whether it supported repayment or refinancing of the February 2014 senior notes.
- Progress toward NYSE listing compliance and the status of Florida approval and execution of Amigo’s run-off plan.
- Subsequent underwriting results, catastrophe losses, combined ratios and reserve development, especially given the reported underwriting losses.
- Debt covenant headroom, deferred trust-preferred interest obligations, and any developments in the customs-bond guarantee or other legal contingencies.